Health Care Up as Risk Appetite Helps Biotech -- Health Care Roundup

Features Dow Jones Newswires

Shares of health-care companies rose as traders rotated back into high-risk biotech shares, encouraged by a perceived easing of "political risk."

Continue Reading Below

Eli Lilly shares rose after an experimental breast cancer drug showed promise in a clinical trial. Shares of Biogen rose ahead of its earnings report later in the week.

(-By Rob Curran,

(END) Dow Jones Newswires

April 24, 2017 16:21 ET (20:21 GMT)